Perseveration and choice in Parkinson's disease: the impact of progressive frontostriatal dysfunction on action decisions.
Hughes LE, Altena E, Barker RA, Rowe JB.
Hughes LE, et al. Among authors: rowe jb.
Cereb Cortex. 2013 Jul;23(7):1572-81. doi: 10.1093/cercor/bhs144. Epub 2012 Jun 1.
Cereb Cortex. 2013.
PMID: 22661404
Free PMC article.
We have previously shown that patients with Parkinson's disease (PD) perseverate in their choice of action relative to healthy controls, and that this is affected by dopaminergic medication (Hughes LE, Barker RA, Owen AM, Rowe JB. 2010. Parkinson's disease and healt …
We have previously shown that patients with Parkinson's disease (PD) perseverate in their choice of action relative to healthy controls, and …